MedPath

NanoPharmaceuticals LLC

NanoPharmaceuticals LLC logo
🇺🇸United States
Ownership
Private
Established
2013-01-01
Employees
1
Market Cap
-
Website
http://www.nanopharmaceuticals.com

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Phase 1
Recruiting
Conditions
Glioma, Malignant
Interventions
First Posted Date
2022-02-07
Last Posted Date
2024-01-26
Lead Sponsor
NanoPharmaceuticals LLC
Target Recruit Count
34
Registration Number
NCT05226494
Locations
🇺🇸

Smilow Cancer Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath